Month: December 2019

California pharmacies rarely take back unused opioids

(Reuters Health) – Only 1 in 10 California pharmacies have programs to take back unused prescription opioids and just one in five give consumers accurate disposal information, according to a study that suggests drugstores could do more to help combat substance abuse.

Samoa ends measles state of emergency as infection rate slows

The South Pacific island nation of Samoa has lifted a six week-state of emergency after the infection rate from a measles outbreak that has swept the country started to come under control.

Chicken pox outbreak forces migrant shelter to shutter in northern Mexico

An outbreak of chicken pox has forced the temporary closure of a shelter housing Central American migrants sent to Mexico from the United States, Mexican authorities said on Friday, as officials sought to contain the highly contagious virus.

Online triage tool may help patients decide if they need immediate care

(Reuters Health) – An online tool that analyzes symptoms may help people decide whether to seek immediate care in the emergency room or to adopt a wait-and-see strategy, a new study suggests.

Almost 10 million in U.S. have faced sexual violence at work

(Reuters Health) – Almost 1 in 18 women and 1 in 40 men have experienced sexual harassment in and related to the workplace, according to a U.S. study.

Transgender children sense their gender identities at young ages

(Reuters Health) – Transgender children may start to identify with toys and clothes typical of their gender identity from a very young age, a recent study suggests.

Recreational marijuana becomes legal in Illinois on New Year’s Day

Many pot-smoking adults in Illinois will ring in the new year on a high note when recreational marijuana use becomes legal in the state on Jan. 1.

Roche dives deeper into gene therapy with $1.15 billion Sarepta licensing deal

Roche Holding AG made its second major gene therapy deal in a year on Monday, spending $1.15 billion to obtain the rights to Sarepta Therapeutics Inc’s investigational drug to treat duchenne muscular dystrophy (DMD) outside the United States.

Eisai Inc announces U.S. approval for insomnia drug

Japan-based drugmaker Eisai Co’s U.S. subsidiary announced on Sunday that it had received approval from the U.S. Food and Drug Administration for its insomnia treatment in adult patients.

U.S. government says verdict in Bayer’s Roundup case should be reversed

The U.S. Environmental Protection Agency and the Justice Department said a federal appeals court should reverse a lower court verdict finding Bayer AG liable in the case of a California man who blamed its Roundup weed killer for his cancer.

ARE YOU READY? GET IT NOW!
Recieve NuPeak Pro’s Free Nootropics Report
Your Information will never be shared with any third party.